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Lower risk of rheumatoid arthritis 
with oral contraceptive pill
A large Swedish study has found that women who take the oral 
contraceptive pill are at reduced risk of developing rheumatoid 
arthritis. Taking the oral contraceptive pill for ≥7 years was linked to 
the lowest risk of the disease – a 19% reduction.
The study was led by the Karolinska Institute, Stockholm, Sweden, 
and enrolled 5 578 women with rheumatoid arthritis and 4 129 age-
matched controls. Any link between breastfeeding among women 
who had given birth to at least one child was also studied. Researchers 
looked for anti-citrullinated protein antibodies (ACPAs), which are a 
blood marker for rheumatoid arthritis. Results showed that any use 
of the contraceptive pill was linked to a reduced risk of developing 
ACPA-positive rheumatoid arthritis. A lower risk of developing 
rheumatoid arthritis that was noticed in women who had breastfed 
was not significant.
Orellana C, Saevarsdottir S, Klareskog L, et al. Oral contraceptives, breastfeeding and the risk of developing 
rheumatoid arthritis: Results from the Swedish EIRA study. Ann Rheum Dis 2017 (epub 17 August 2017). 
https://doi.org/10.1136/annrheumdis-2017-211620
Still large numbers of children under 
5 dying of tuberculosis
Nearly 200 000 children aged <5 years died from tuberculosis (TB) 
in 2015, most in sub-Saharan Africa, a study published in Lancet 
Global Health has shown. Researchers from the University of 
Sheffield, UK, using mathematical modelling to show death rates 
from TB in under-5s for the first time, found that 239 000 children 
aged ≤14 died of TB in 2015 and 80% of these were aged <5.
This high number of deaths implies that TB should rank as a 
major cause of death in children aged <5 years worldwide. In fact, 
the number of deaths is likely to be higher, because some deaths from 
pneumonia, meningitis or AIDS may be caused by TB. The data also 
showed that 17% of children who died of TB were HIV-positive. More 
than 90% of the deaths were in children who were not receiving TB 
treatment, meaning that more needs to be done to identify children 
at risk of disease, diagnose their condition and treat them correctly.
Dodd  PJ,  Yuen  CM,  Sismanidis  C,  Seddon  JA,  Jenkins  HE. The global burden of tuberculosis mortality 
in children: A mathematical modelling study.  Lancet Glob Health 2017;358:e898-e906.  https://doi.
org/10.1016/S2214-109X(17)30289-9 
Alternative cancer treatment linked  
to greater risk of death
The sole use of alternative medicine therapies by patients with cancer 
results in more than twice the risk of death from the disease compared 
with death rates associated with conventional cancer treatment.
A study published in JNCI: Journal of the National Cancer Institute 
and carried out by Skyper B Johnson and colleagues from the Yale 
School of Medicine identified 281 patients from the US National 
Cancer Database from 2004 to 2013 with breast, prostate, lung or 
colorectal cancer who chose alternative medicine therapy as their 
only anticancer treatment. Patients with metastatic disease were not 
included.
The survival rates of patients who chose alternative medicine 
were compared with those of 560 matched patients who underwent 
conventional cancer treatment, defined as chemotherapy, 
radiotherapy, surgery or hormone therapy. Alternative medicine was 
defined as treatment coded in the database as ‘other or unproven: 
cancer treatments administered by nonmedical personnel’. The 
median follow-up was 66 months.
The risk varied by type of cancer, the worst outcomes being among 
those who chose alternative therapy to treat breast cancer, followed 
by colorectal and lung cancer. Prostate cancer appeared not to be 
affected, possibly because of the long natural history of the disease 
and the short median follow-up period.
Johnson SB, Park HS, Gross CP, Yu JB. Use of alternative medicine for cancer and its impact on survival. J 
Natl Cancer Inst 2017 (epub 10 August 2017). https://doi.org/10.1093/jnci/djx145
‘Five a day’ may be more than we need
The recent PURE (Prospective Urban Rural Epidemiology) study 
suggests that, while high fruit and vegetable consumption is asso-
ciated with a lower risk of non-cardiovascular and total mortality, the 
maximum benefits appear at three to four servings a day.
The study followed 135  335 individuals without cardiovascular 
disease from 613 communities in 18 low-, middle- and high-income 
countries in North America and Europe, South America, the Middle 
East, south Asia, China and southeast Asia and Africa between 2003 
and 2013. Country-specific food questionnaires were collected, 
along with information on smoking and other lifestyle factors.
Overall, 3.9 servings of fruit, vegetables and legumes were eaten 
daily, and there was no decrease in cardiovascular or other disease 
with higher daily consumption. Fruit consumption was specifically 
associated with a lower risk of all-cause mortality, legumes with a 
lower risk of cardiovascular mortality, and raw vegetables with a 
lower risk of total mortality. The number of servings associated with 
maximum benefits are equivalent to 375 - 500 g/day.
Miller V, Mente A, Dehghan M, et al. Fruit, vegetable, and legume intake, and cardiovascular disease and 
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